Intrinsic Value of S&P & Nasdaq Contact Us

Inari Medical, Inc. NARI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
40/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$67.56
-15.5%

There have been 50 recent insider transactions recorded for Inari Medical, Inc. (NARI), including 5 buys and 43 sells. Total insider buying was valued at RSU Award and total insider selling at $13.11M.

Notable insiders with recent activity include Mead Dana G Jr., Root Jonathan D, Milder Donald B. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — NARI

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2025-02-19 Mead Dana G Jr. Director Tender Offer (Sell) 11,148 - - -
2025-02-19 Root Jonathan D Director Tender Offer (Sell) 335 - - -
2025-02-19 Milder Donald B Director Tender Offer (Sell) 2,831,714 - - -
2025-02-19 Hoffman William Director Tender Offer (Sell) 238,987 - - -
2025-02-19 Lucchese Cynthia L Director Return of Shares 49,719 $5.73 $284.71K -
2025-02-19 Szyman Catherine M. Director Return of Shares 49,719 $5.73 $284.71K -
2025-02-19 Tu Thomas Chief Medical Officer Tender Offer (Sell) 478,767 - - -
2025-02-19 Hykes Andrew President and CEO Return of Shares 44,693 $58.44 $2.61M -
2025-02-19 Chambers Rebecca Director Tender Offer (Sell) 9,684 - - -
2025-02-19 Warner Robert Keith Director Tender Offer (Sell) 12,149 - - -
2025-02-19 Strange Kevin T Chief Financial Officer Return of Shares 5,293 $58.44 $309.32K -
2025-02-19 Silva Karen Principal Accounting Officer Tender Offer (Sell) 14,719 - - -
2025-02-10 Tu Thomas Chief Medical Officer Option Exercise (Sell) 8,420 $6.45 $54.35K -
2025-02-10 Hykes Andrew President and CEO Option Exercise (Sell) 16,719 $0.46 $7.64K -
2025-02-04 Tu Thomas Chief Medical Officer RSU Award 21,102 - - 323,357
2025-02-04 Hykes Andrew President and CEO RSU Award 67,282 - - 502,706
2025-02-04 Strange Kevin T Chief Financial Officer RSU Award 21,102 - - 67,502
2025-02-04 Silva Karen Principal Accounting Officer RSU Award 5,504 - - 14,719
2025-01-06 Hoffman William Director Informative Sell 58,925 $61.27 $3.61M 238,987
2025-01-01 Hoffman William Director Tax Withholding of RSU 1,533 $51.05 $78.26K 438,987
2025-01-01 Tu Thomas Chief Medical Officer Tax Withholding of RSU 516 $51.05 $26.34K 301,733
2025-01-01 Hykes Andrew President and CEO Tax Withholding of RSU 1,319 $51.05 $67.33K 434,901
2025-01-01 Strange Kevin T Chief Financial Officer Tax Withholding of RSU 146 $51.05 $7.45K 46,318
2024-12-20 Hykes Andrew President and CEO Informative Sell 600 $55.65 $33.39K 439,310
2024-12-16 Hoffman William Director Informative Sell 132 $56.89 $7.51K 441,233
2024-12-10 Tu Thomas Chief Medical Officer Informative Sell 4,000 $55.00 $220K 304,036
2024-12-01 Silva Karen Principal Accounting Officer RSU Award 9,215 - - 9,215
2024-11-20 Hykes Andrew President and CEO Informative Sell 3,000 $50.83 $152.49K 442,310
2024-11-18 Hoffman William Director Informative Sell 9,750 $51.16 $498.81K 501,233
2024-11-11 Silva Karen Principal Accounting Officer Unknown - - - -
2024-10-29 Hoffman William Director Informative Sell 20,000 $50.00 $1M 561,233
2024-10-29 Hykes Andrew President and CEO Informative Sell 3,000 $50.00 $150K 445,310
2024-10-16 Hoffman William Director Informative Sell 12,196 $45.57 $555.77K 601,233
2024-10-01 Hill, Mitch C. Chief Financial Officer Tax Withholding of RSU 458 $40.63 $18.61K 177,533
2024-10-01 Hoffman William Director Tax Withholding of RSU 1,385 $40.63 $56.27K 641,233
2024-10-01 Tu Thomas Chief Medical Officer Tax Withholding of RSU 470 $40.63 $19.1K 308,036
2024-10-01 Hykes Andrew President and CEO Tax Withholding of RSU 1,292 $40.63 $52.49K 448,310
2024-10-01 Strange Kevin T Chief Financial Officer Unknown 5,293 $56.00 $296.41K -
2024-10-01 Strange Kevin T Chief Financial Officer Tax Withholding of RSU 240 $40.63 $9.75K 47,355
2024-09-16 Hoffman William Director Informative Sell 7,386 $46.27 $341.75K 643,296
2024-09-12 Hill, Mitch C. Chief Financial Officer Option Exercise (Sell) 3,000 $0.46 $1.37K 58,477
2024-08-20 Hykes Andrew President and CEO Informative Sell 3,000 $50.00 $150K 452,532
2024-08-19 Hoffman William Director Informative Sell 20,000 $50.30 $1.01M 683,296
2024-08-16 Hoffman William Director Informative Sell 15,447 $49.17 $759.53K 703,296
2024-08-12 Hill, Mitch C. Chief Financial Officer Option Exercise (Sell) 5,000 $0.46 $2.29K 61,477
2024-07-22 Hykes Andrew President and CEO Informative Sell 3,000 $55.23 $165.69K 455,252
2024-07-16 Hoffman William Director Informative Sell 3,243 $58.17 $188.65K 743,296
2024-07-16 Tu Thomas Chief Medical Officer Informative Sell 3,480 $55.16 $191.96K 309,777
2024-07-15 Tu Thomas Chief Medical Officer Informative Sell 3,300 $55.10 $181.83K 313,257
2024-07-12 Hill, Mitch C. Chief Financial Officer Option Exercise (Sell) 5,000 $0.46 $2.29K 66,477
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message